Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main goal of this trial is to evaluate the safety and immunogenicity of the candidate N. gonorrhoeae vaccine, LTB-NG6.
Epistemonikos ID: 87abd11504f7bd88fe93391e3d4a689a02c4376f
First added on: Aug 12, 2026